| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |